BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130
20 results:

  • 1. Bazedoxifene, a gp130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical cancer.
    Kim L; Park SA; Park H; Kim H; Heo TH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445405
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
    Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
    Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Is lymph node dissection mandatory among early stage endometrial cancer patients? A retrospective study.
    Zhang G; Chen H; Liu Y; Niu L; Jin L; Li D; Song L; Shang L; Lin X; Wang F; Li F; Zhang X; Zhang X; Gao Y; Qiu D; Zhang Y; Na R; Su R
    BMC Womens Health; 2020 Nov; 20(1):258. PubMed ID: 33213444
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Enhanced recovery for obese patients undergoing gynecologic cancer surgery.
    Harrison R; Iniesta MD; Pitcher B; Ramirez PT; Cain K; Siverand AM; Mena G; Lasala J; Meyer LA
    Int J Gynecol Cancer; 2020 Oct; 30(10):1595-1602. PubMed ID: 32848023
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Suradej B; Sookkhee S; Panyakaew J; Mungkornasawakul P; Wikan N; Smith DR; Potikanond S; Nimlamool W
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470515
    [No Abstract]    [Full Text] [Related]  

  • 6. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
    Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
    Parsons LHP; Pedersen R; Richardson DL; Kho KA
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Rapamycin Synergizes with Cisplatin in Antiendometrial cancer Activation by Improving IL-27-Stimulated Cytotoxicity of NK Cells.
    Zhou WJ; Chang KK; Wu K; Yang HL; Mei J; Xie F; Li DJ; Li MQ
    Neoplasia; 2018 Jan; 20(1):69-79. PubMed ID: 29195127
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. IL6/JAK1/STAT3 Signaling Blockade in Endometrial cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden.
    van der Zee M; Sacchetti A; Cansoy M; Joosten R; Teeuwssen M; Heijmans-Antonissen C; Ewing-Graham PC; Burger CW; Blok LJ; Fodde R
    Cancer Res; 2015 Sep; 75(17):3608-22. PubMed ID: 26130650
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.
    Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
    BMC Cancer; 2014 Feb; 14():140. PubMed ID: 24575810
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing.
    Tamm-Rosenstein K; Simm J; Suhorutshenko M; Salumets A; Metsis M
    PLoS One; 2013; 8(7):e68907. PubMed ID: 23874806
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. uterine artery embolization of large fibroids: comparative study of procedure with and without pretreatment gonadotropin-releasing hormone agonists.
    Kim MD; Lee M; Lee MS; Park SI; Wonq JY; Lee DY; Lee KH
    AJR Am J Roentgenol; 2012 Aug; 199(2):441-6. PubMed ID: 22826410
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of leukemia inhibitory factor in the endometrium in abnormal uterine cavities during the implantation window.
    Hasegawa E; Ito H; Hasegawa F; Hatano K; Kazuka M; Usuda S; Isaka K
    Fertil Steril; 2012 Apr; 97(4):953-8. PubMed ID: 22341639
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.
    Sales KJ; Grant V; Cook IH; Maldonado-Pérez D; Anderson RA; Williams AR; Jabbour HN
    Am J Pathol; 2010 Jan; 176(1):435-45. PubMed ID: 20008143
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression.
    Suman P; Poehlmann TG; Prakash GJ; Markert UR; Gupta SK
    J Reprod Immunol; 2009 Oct; 82(1):1-11. PubMed ID: 19716605
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: a retrospective analysis of 556 patients from India.
    Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Ghoshal S; Kumar V; Kapoor R
    Radiother Oncol; 2006 May; 79(2):142-6. PubMed ID: 16677730
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Temozolomide in uterine leiomyosarcomas.
    Anderson S; Aghajanian C
    Gynecol Oncol; 2005 Jul; 98(1):99-103. PubMed ID: 15916799
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients.
    Kovacs E
    Biomed Pharmacother; 2001 Sep; 55(7):391-6. PubMed ID: 11669502
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production.
    Hess S; Smola H; Sandaradura De Silva U; Hadaschik D; Kube D; Baldus SE; Flucke U; Pfister H
    J Immunol; 2000 Aug; 165(4):1939-48. PubMed ID: 10925276
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Response to IL-6 of HPV-18 cervical carcinoma cell lines.
    Bauknecht T; Randelzhofer B; Schmitt B; Ban Z; Hernando JJ
    Virology; 1999 Jun; 258(2):344-54. PubMed ID: 10366571
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.